-
-
>News
-
>General News
As cases of dengue fever surge globally, health authorities are urging communities to remain vigilant against this potentially deadly mosquito-borne illness. As of the first half of 2024, over 10 million cases of dengue have been reported from 176 countries across all WHO regions, with more than 24,000 severe cases and 6,508 deaths, raising concerns about the spread of the virus and its impact on public health.
Understanding Dengue Virus
Dengue virus, transmitted primarily by Aedes mosquitoes, has four serotypes (DENV-1, DENV-2, DENV-3, DENV-4). Infection can lead to symptoms ranging from mild fever and rash to severe conditions such as dengue hemorrhagic fever and dengue shock syndrome. Common symptoms include high fever, severe headache, joint and muscle pain, and skin rashes, which typically appear 3 to 14 days after the bite of an infected mosquito.
Transmission and Prevention
Dengue is predominantly spread through the bite of an infected Aedes aegypti or Aedes albopictus mosquito. These mosquitoes thrive in tropical and subtropical climates, with urban areas being particularly vulnerable. Preventative measures include reducing mosquito habitats, using insect repellent, and employing protective clothing to minimize exposure.
Currently, there is no specific antiviral treatment for dengue fever. Management primarily focuses on supportive care, including hydration and pain relief. Severe cases may require hospitalization for intravenous fluid management and monitoring.
Tianlong's Innovative Solutions
To aid in the rapid detection and management of dengue, Tianlong Technology offers advanced diagnostic solutions:
The Dengue virus is classified into four serotypes: I, II, III, and IV, based on their antigenicity. Within each serotype, different strains may also exhibit antigenic variations. Type II is the most widely distributed. There is antigenic crossover among the various serotypes, with some antigens being similar to those of the B Encephalitis Virus and the West Nile Virus. Identifying the serotype of a dengue virus infection is crucial for guiding symptomatic treatment.
This kit allows for precise identification of the four dengue virus serotypes, essential for appropriate clinical management and outbreak control.
This multiplex detection kit is designed for the qualitative detection of Dengue Virus, Zika Virus, and Chikungunya Virus nucleic acids using the Real-time Reverse Transcription Polymerase Chain Reaction (Real-time RT-PCR) method. The test results indicate the presence of RNA from Dengue Virus, Zika Virus, or Chikungunya Virus in the tested serum samples.
This kit facilitates the simultaneous identification of dengue, Zika, and Chikungunya viruses, ensuring timely diagnosis and effective public health response.
As we face the challenges posed by the recent dengue outbreak, it is crucial for communities to be informed and prepared. Tianlong is committed to supporting public health efforts with innovative solutions that enhance disease detection and management. For more information about our products and how we can assist your community, please visit Tianlong.
